UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Cisplatin, Dacarbazine With or Without Subcutaneous Interleukin-2, and Interferon Alfa-2b in Advanced Melanoma Outpatients: Results From an Italian Multicenter Phase III Randomized Clinical Trial

Journal of clinical oncology, 2002-03, Vol.20 (6), p.1600-1607

Ridolfi, R.

2002

Link zum Volltext

Verfügbarkeit prüfen

Predictive and Prognostic Role of Tumor‐Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting

The oncologist (Dayton, Ohio), 2016-03, Vol.21 (3), p.283-291

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer

Critical reviews in oncology/hematology, 2018-09, Vol.129, p.54-66

2018

Link zum Volltext

Verfügbarkeit prüfen

Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: Sensitivity analysis of randomized trials

Cancer treatment reviews, 2015-03, Vol.41 (3), p.262-270

2015

Link zum Volltext

Verfügbarkeit prüfen

The involvement of early stage breast cancer patients during oncology consultations in Italy: a multi-centred, randomized controlled trial of a question prompt sheet versus question listing

BMJ open, 2017-08, Vol.7 (8), p.e015079-e015079

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials

Cancer treatment reviews, 2014-08, Vol.40 (7), p.847-856

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research

Expert opinion on biological therapy, 2017-04, Vol.17 (4), p.497-506

2017

Link zum Volltext

Verfügbarkeit prüfen

Propensity score analysis investigating the role of hormonal maintenance (HM) for advanced breast carcinoma with luminal subtype (ABC-Lum): Implication for prognostic modeling, post-progression and conditional survival (PPS/CS)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.545-545

2016

Link zum Volltext

Verfügbarkeit prüfen

Cut-off analysis and prognostic relevance of Ki67 for resected early stage pure invasive lobular breast carcinoma (ILC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.544-544

2016

Link zum Volltext

Verfügbarkeit prüfen

Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge

Neurological sciences, 2015-01, Vol.36 (1), p.117-123

2015

Link zum Volltext

Verfügbarkeit prüfen

A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in a multi-center series of resected early stage pure invasive lobular breast carcinoma (ILC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.539-539

2017

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives

Anti-cancer agents in medicinal chemistry, 2015-01, Vol.15 (1), p.15

2015

Link zum Volltext

Verfügbarkeit prüfen

Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer

Journal of experimental & clinical cancer research, 2016-03, Vol.35 (1), p.50-50, Article 50

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of single/dual HER2 inhibition and chemotherapy (CT) backbone upon pathologic complete response (pCR) in patients receiving neoadjuvant CT for operable/locally advanced breast cancer (O/LABC): A treatment-interaction analysis of randomized trials

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.630-630

2012

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : Results of an Italian multicenter, randomized, phase II study

Cancer, 2006-12, Vol.107 (12), p.2898-2905

2006

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy for metastatic melanoma

Expert review of anticancer therapy, 2006-01, Vol.6 (1), p.121-130

2006

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site

Cancer, 2006-12, Vol.107 (12), p.2898-2905

2006

Link zum Volltext

Verfügbarkeit prüfen

Ki‐67 immunostaining in 322 primary breast cancers: Associations with clinical and pathological variables and prognosis

International journal of cancer, 1997-08, Vol.74 (4), p.433-437

1997

Link zum Volltext

Verfügbarkeit prüfen

Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma

Melanoma research, 2006-08, Vol.16 (4), p.317-323

2006

Link zum Volltext

Verfügbarkeit prüfen

Identification of Clinical Prognostic Factors in Patients with Unknown Primary Tumors Treated with a Platinum-Based Combination

Oncology, 2005-01, Vol.69 (2), p.135-144

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Female
(23)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Oncology
(21)
Breast Cancer
(14)
Middle Aged
(13)
Prognosis
(13)
Breast Neoplasms - Pathology
(12)
Adult
(11)
Aged
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Survival Analysis
(8)
Breast Neoplasms - Drug Therapy
(7)
Retrospective Studies
(7)
Chemotherapy
(6)
Tumors
(6)
Disease-Free Survival
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cisplatin, Dacarbazine With or Without Subcutaneous Interleukin-2, and Interferon Alfa-2b in Advanced Melanoma Outpatients: Results From an Italian Multicenter Phase III Randomized Clinical Trial

Predictive and Prognostic Role of Tumor‐Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting

Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer

Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: Sensitivity analysis of randomized trials

The involvement of early stage breast cancer patients during oncology consultations in Italy: a multi-centred, randomized controlled trial of a question prompt sheet versus question listing

Next-generation targeted sequencing (NGTS) investigating CDK4 as a prognostic driver in pure invasive lobular breast carcinoma (ILC): Preliminary results in early-stage patients (pts) stratified according to a validated clinico-pathological model

Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials

Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research

Prognostic impact of proliferation for resected early stage ‘pure’ invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation

Propensity score analysis investigating the role of hormonal maintenance (HM) for advanced breast carcinoma with luminal subtype (ABC-Lum): Implication for prognostic modeling, post-progression and conditional survival (PPS/CS)

Cut-off analysis and prognostic relevance of Ki67 for resected early stage pure invasive lobular breast carcinoma (ILC)

Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge

A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in a multi-center series of resected early stage pure invasive lobular breast carcinoma (ILC)

Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival

Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives

Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer

Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel

Impact of single/dual HER2 inhibition and chemotherapy (CT) backbone upon pathologic complete response (pCR) in patients receiving neoadjuvant CT for operable/locally advanced breast cancer (O/LABC): A treatment-interaction analysis of randomized trials

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : Results of an Italian multicenter, randomized, phase II study

INvolvement of breast CAncer patients during oncological consultations: a multicentre randomised controlled trial—the INCA study protocol

Chemotherapy for metastatic melanoma

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site

Ki‐67 immunostaining in 322 primary breast cancers: Associations with clinical and pathological variables and prognosis

Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma

Identification of Clinical Prognostic Factors in Patients with Unknown Primary Tumors Treated with a Platinum-Based Combination

Suchergebnisse filtern